# A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants

> **NCT02310425** · PHASE3 · COMPLETED · sponsor: **Lingfen Xu, MD** · enrollment: 125 (actual)

## Conditions studied

- Infant, Premature, Diseases

## Interventions

- **DRUG:** S. boulardii
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02310425
- **Lead sponsor:** Lingfen Xu, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-07
- **Final completion:** 2014-01
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2014-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02310425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02310425, "A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02310425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*